Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

CUSIP: 640268108

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
20,788,527
Total 13F shares
7,254
Share change
+806
Total reported value
$412,697
Price per share
$56.90
Number of holders
8
Value change
+$299,814
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q3 2025

As of 30 Sep 2025, Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,254 shares. The largest 8 holders included 49 WEALTH MANAGEMENT, LLC, Parallel Advisors, LLC, EverSource Wealth Advisors, LLC, Rise Advisors, LLC, Fortitude Family Office, LLC, AllSquare Wealth Management LLC, HUNTINGTON NATIONAL BANK, and LRI Investments, LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.